← Evidence map

Observational studyViruses2022

Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection.

Kentaro Nagaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35891380